ZW9680A1 - 2-aminoalkyl-5-pyridinols process for their manufacture pharmaceutical preparations containing these compounds and their therapeutic application - Google Patents

2-aminoalkyl-5-pyridinols process for their manufacture pharmaceutical preparations containing these compounds and their therapeutic application

Info

Publication number
ZW9680A1
ZW9680A1 ZW96/80A ZW9680A ZW9680A1 ZW 9680 A1 ZW9680 A1 ZW 9680A1 ZW 96/80 A ZW96/80 A ZW 96/80A ZW 9680 A ZW9680 A ZW 9680A ZW 9680 A1 ZW9680 A1 ZW 9680A1
Authority
ZW
Zimbabwe
Prior art keywords
formula
compounds
xii
pyridinols
aminoalkyl
Prior art date
Application number
ZW96/80A
Other languages
English (en)
Inventor
Renat Herbert Mizzoni
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of ZW9680A1 publication Critical patent/ZW9680A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Building Environments (AREA)
  • Paper (AREA)
ZW96/80A 1979-05-03 1980-04-30 2-aminoalkyl-5-pyridinols process for their manufacture pharmaceutical preparations containing these compounds and their therapeutic application ZW9680A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3566879A 1979-05-03 1979-05-03

Publications (1)

Publication Number Publication Date
ZW9680A1 true ZW9680A1 (en) 1980-11-26

Family

ID=21884070

Family Applications (1)

Application Number Title Priority Date Filing Date
ZW96/80A ZW9680A1 (en) 1979-05-03 1980-04-30 2-aminoalkyl-5-pyridinols process for their manufacture pharmaceutical preparations containing these compounds and their therapeutic application

Country Status (19)

Country Link
EP (1) EP0019739B1 (xx)
JP (1) JPS55149260A (xx)
AT (1) ATE8501T1 (xx)
DD (1) DD150461A5 (xx)
DE (1) DE3068577D1 (xx)
DK (1) DK157540C (xx)
ES (1) ES491055A0 (xx)
FI (1) FI70212C (xx)
GB (1) GB2050380B (xx)
GR (1) GR68206B (xx)
HU (1) HU181115B (xx)
IE (1) IE49712B1 (xx)
IL (1) IL59978A (xx)
MA (1) MA18964A1 (xx)
NO (1) NO154130C (xx)
OA (1) OA06528A (xx)
PL (1) PL223984A1 (xx)
PT (1) PT71176A (xx)
ZW (1) ZW9680A1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4746670A (en) * 1986-04-11 1988-05-24 Ciba-Geigy Corporation Use of 2-aminoalkyl-5-pyridinols as nootropic agents and antidepressants
JP4732662B2 (ja) * 2000-04-06 2011-07-27 セイコーインスツル株式会社 電子時計の電池保持構造

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3952101A (en) * 1975-04-14 1976-04-20 Smithkline Corporation α-Amino methyl-5-hydroxy-2-pyridinemethanols

Also Published As

Publication number Publication date
JPS6365662B2 (xx) 1988-12-16
FI70212B (fi) 1986-02-28
EP0019739B1 (de) 1984-07-18
ES8104229A1 (es) 1981-04-01
HU181115B (en) 1983-06-28
IE800899L (en) 1980-11-03
MA18964A1 (fr) 1980-12-31
IL59978A0 (en) 1980-07-31
FI801411A (fi) 1980-11-04
NO801267L (no) 1980-11-04
EP0019739A1 (de) 1980-12-10
DK157540B (da) 1990-01-22
DE3068577D1 (en) 1984-08-23
PL223984A1 (xx) 1981-02-13
IE49712B1 (en) 1985-11-27
GR68206B (xx) 1981-11-10
GB2050380A (en) 1981-01-07
GB2050380B (en) 1983-07-20
JPS55149260A (en) 1980-11-20
DD150461A5 (de) 1981-09-02
ES491055A0 (es) 1981-04-01
OA06528A (fr) 1981-07-31
IL59978A (en) 1984-03-30
FI70212C (fi) 1986-09-15
PT71176A (en) 1980-05-01
ATE8501T1 (de) 1984-08-15
NO154130B (no) 1986-04-14
DK193180A (da) 1980-11-04
NO154130C (no) 1986-07-23
DK157540C (da) 1990-06-11

Similar Documents

Publication Publication Date Title
ES8104286A1 (es) Un procedimiento para la produccion de un derivado 4-amino- 3-carboxi o ciano-1,2-dihidro-2-oxo-1,8-naftiridina
DE3363244D1 (en) Compounds, process for their preparation and their use as pharmaceutical preparations
DE3171467D1 (en) Mannich-base hydroxamic acid prodrugs for the improved bioavailability of non-steroidal anti-inflammatory agents, a process for preparing and a pharmaceutical composition containing them
ES8301927A1 (es) Procedimiento de preparacion de acidos azabiciclohexano car-boxilicos y de sus sales
ES2000604A6 (es) Un procedimiento para preparar aril-piperidin esteres
HUT46895A (en) Process for production of new 5-lipoxigenase bicyclic compounds with inhibiation effect
ES8706610A1 (es) Proceso para preparar un derivado de aminoalcohol.
ZW9680A1 (en) 2-aminoalkyl-5-pyridinols process for their manufacture pharmaceutical preparations containing these compounds and their therapeutic application
ES8104309A1 (es) Procedimiento para preparar enaminas
DE3260303D1 (en) Process for the preparation of 4-quinolinones
ES8401059A1 (es) Procedimiento para la preparacion de fenoleteres biciclicos.
GB871235A (en) Novel substituted pyrrolidones and salts thereof and a process for the manufacture of same
ES473484A1 (es) Un procedimiento para la preparacion de nuevos eteres del acido clavulanico